Articles
May 29, 2020
Biologics and biosimilars in Brazil – the strategic questions
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
Click below to access the full chapter.
Back
Share:
Last related news
August 17, 2021
Privacy in Brazil 2021
The Q&A guide gives a high-level overview of privacy rules and principles, including what national laws regulate the right to respect for … Privacy in Brazil 2021
July 5, 2021
Personalised medicine in Brazil: IP and regulatory challenges
Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first … Personalised medicine in Brazil: IP and regulatory challenges
May 18, 2021
Anti-counterfeiting and Online Brand Enforcement: A Global Guide 2021
The growth of the Brazilian market and economy is paralleled by the increase in counterfeiting activities. The enforcement of IP rights involves … Anti-counterfeiting and Online Brand Enforcement: A Global Guide 2021